Sutro Biopharma
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $9,839 | $14,523 | $11,647 | $9,693 |
Gross Profit | 9,839 | 13,245 | 11,647 | 9,693 |
EBITDA | -27,408 | -27,754 | -34,891 | -44,550 |
EBIT | -28,670 | -29,032 | -36,515 | -46,450 |
Net Income | -38,533 | -38,484 | -46,762 | -56,857 |
Net Change In Cash | 9,839 | 14,523 | 11,647 | 9,693 |
Free Cash Flow | -38,290 | -42,270 | -26,619 | -38,440 |
Cash | 54,335 | 73,682 | 58,130 | 65,927 |
Basic Shares | 16,571 | 13,082 | 8,584 | 8,486 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $102,484 | $62,043 | $153,731 | $67,772 |
Gross Profit | 95,160 | 54,825 | 146,915 | 59,484 |
EBITDA | -145,647 | -180,453 | -67,915 | -105,070 |
EBIT | -152,971 | -187,671 | -74,731 | -113,358 |
Net Income | -191,086 | -227,461 | -106,793 | -119,204 |
Net Change In Cash | 102,484 | 62,043 | 153,731 | 67,772 |
Free Cash Flow | -178,926 | -194,638 | -115,931 | -4,309 |
Cash | 58,130 | 190,304 | 69,268 | 47,254 |
Basic Shares | 8,497 | 7,682 | 6,016 | 5,073 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$2.33 |
2026-03-31 | -$2.94 |
2025-12-31 | -$5.44 |
2025-09-30 | -$5.57 |